WHO likely to take decision on emergency listing of Covaxin in Four to Six weeks

A new development has been made in the Bharat Biotech's Covid-19 vaccine Covaxin where the World Health Organization ( WHO) is likely to make a decision where they can use Covaxin in the emergency use list ( EUL) within four to six weeks. On this matter, Soumya Swaminathan, the global health body's chief scientist has said, There is a process to be followed for EUL and pre-qualification of vaccines under which a company has to complete phase 3 trials and submit the whole data to the regulatory department of WHO which is examined by an expert advisory group. If WHO accepts the Covaxin vaccine in the EUL then this is will be a big development for India.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting